Tag: Osteoporosis
Zydus Lifesciences’ Menostar Transdermal System generic gets FDA final approval
Zydus Lifesciences has secured final approval from the UA Food and Drug Administration (FDA) for Estradiol Transdermal System USP, 0.014 mg/day. The approved product which ... Read More
Biocon Biologics signs licensing deal for two biosimilars with Yoshindo
Biocon Ltd. said that its subsidiary Biocon Biologics has signed an out-licensing agreement with Japanese pharma company Yoshindo Inc. for commercializing a couple of its ... Read More
NaQuinate : Haoma Medica completes human trial of osteoporosis candidate
Haoma Medica has wrapped up a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as an oral treatment for osteoporosis. The ... Read More
Ways to strengthen your bones to prevent Osteoporosis
Bones are constantly broken down to develop new bones and a balance should be maintained between these two processes as if more bone is lost ... Read More
Amgen, UCB resubmit BLA of EVENITY osteoporosis drug to FDA
Amgen and UCB have resubmitted the biologics license application (BLA) of their investigational osteoporosis drug EVENITY (romosozumab) to the US Food and Drug Administration (FDA) ... Read More